Add to a list

Inactive Instrument

Tilray, Inc. Share Price Toronto S.E.

APHA

CA03765K1049

Last Transcript: Tilray, Inc.

Tilray Brands, Inc., Q4 2026 Earnings Call, Jul 28, 2026

07-29

More transcripts

Analysts' recommendations: Tilray, Inc.

04-02	Tilray Brands Shares Rise After Roth Capital Upgrade	MT
04-02	Roth Capital Upgrades Tilray Brands to Buy From Neutral, Price Target is $10	MT
29/09/25	Wall Street indexes climb as investors brush off government shutdown uncertainties	RE
09/04/25	Piper Sandler on Tilray: Canadian Cannabis Still Pressured, Guidance Lowered	MT
13/01/25	Piper Sandler Reviews Tilray's Q2	MT

More recommendations

News in other languages: Tilray, Inc.

04-23	Les États-Unis reclassent le cannabis dans une catégorie moins restrictive
04-23	Les USA reclassent le cannabis dans une catégorie moins restrictive
04-23	EEUU relaja normativa sobre la marihuana, un sector de 47.000 millones de dólares
04-23	Reclassement du cannabis aux Etats-Unis : les valeurs du secteur s'envolent en Bourse
12-18	MÄRKTE USA/Zinssenkungshoffnung und Micron geben Aktien Auftrieb

More news

Managers and Directors: Tilray, Inc.

Manager	Title	Age	Since
Irwin Simon CEO	Chief Executive Officer	67	30/04/2021
Carl Merton DFI	Director of Finance/CFO	57	30/04/2021
Lloyd Brathwaite CTO	Chief Tech/Sci/R&D Officer	-	29/04/2021

Director	Title	Age	Since
Irwin Simon CHM	Chairman	67	30/04/2021
David Clanachan BRD	Director/Board Member	64	29/04/2021
John Herhalt BRD	Director/Board Member	69	30/04/2021

More insiders

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services.

Employees

3,595

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	633M 547M 514M 467M 879M 60.56B 893M 6.02B 2.35B 30.33B 2.38B 2.33B 101B	P/E 2027 *	-9.26x	P/E 2028 *	-21.6x
Enterprise Value	607M 524M 492M 448M 842M 58B 856M 5.77B 2.26B 29.04B 2.28B 2.23B 96.51B	EV / Sales 2027 *	0.54x	EV / Sales 2028 *	0.5x
Free-Float	98.49%	Yield 2027 *	-	Yield 2028 *	-

08-11	Tilray Brands, Inc. Enters Energy Drink Distribution Agreement With Wolverhampton Wanderers Football Club	CI
08-06	Tilray Brands Launches Mollo Lite Blackberry Lemon Seltzer Multi-Pack	CI
07-29	Tilray Brands, Inc., Q4 2026 Earnings Call, Jul 28, 2026
07-28	Tilray Brands Fiscal Q4 Adjusted Earnings Fall, Revenue Rises	MT
07-28	Tilray Brands Reports Lower Adjusted Earnings, Higher Revenue for Fiscal Q4	MT
07-28	Tilray Brands, Inc. to Seek Acquisitions	CI
07-28	Tilray Brands, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2026	CI
07-23	Tilray Brands Launches New Cannabis Brand ZONNA	MT
07-17	Tilray Brands' BrewDog Kicks Off 1 Million Pound Bar Tab in The UK	MT
07-14	Second Best proposed to acquire BrewDog PLC from Tilray Brands, Inc..	CI
07-09	Tilray Medical Launches First Medical Cannabis Product in Panama	CI
07-09	Tilray Brands Unit Launches First Medical Cannabis Product in Panama	MT
07-09	Tilray Medical Launches First Medical Cannabis Product in Panama	MT

08-11	Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership	AQ
08-11	BrewDog Claims London's Summer Park Season with 'Park IPA'	AQ
08-10	BrewDog Claims London's Summer Park Season with ‘Park IPA’	AQ
07-28	Tilray Brands : Annual Report for Fiscal Year Ending 05-31, 2026 (Form 10-K)	PU
07-16	Brewdog's new owner shrugs off Watt's bid	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TILRAY, INC.	-5.59%	-15.99%	-	-	633M
ELI LILLY AND COMPANY	-2.25%	-0.47%	+68.30%	+115.90%	1,052B
JOHNSON & JOHNSON	-0.66%	+0.43%	+47.39%	+50.54%	627B
ABBVIE INC.	-0.54%	+1.39%	+20.69%	+63.99%	441B
ROCHE HOLDING AG	-1.99%	-3.32%	+38.71%	+35.41%	349B
NOVARTIS AG	-1.05%	-2.81%	+23.07%	+35.70%	287B
ASTRAZENECA PLC	-2.12%	-3.67%	-1.14%	+5.37%	241B
AMGEN INC.	-0.63%	+1.04%	+40.05%	+56.09%	224B
NOVO NORDISK A/S	-1.19%	-3.41%	-9.57%	-52.71%	202B
GILEAD SCIENCES, INC.	+0.16%	+3.87%	+16.89%	+73.73%	172B
Average	-1.59%	+0.43%	+27.15%	+42.67%	399.46B
Weighted average by Cap.	-1.36%	+0.32%	+39.09%	+61.29%

	2027 *	2028 *
Net sales	1.12B 970M 911M 829M 1.56B 107B 1.58B 10.68B 4.17B 53.76B 4.22B 4.12B 179B	1.18B 1.02B 955M 869M 1.63B 113B 1.66B 11.19B 4.38B 56.35B 4.42B 4.32B 187B
Net income	-61.49M -53.11M -49.91M -45.39M -85.33M -5.88B -86.74M -585M -229M -2.94B -231M -226M -9.78B	-26.86M -23.2M -21.8M -19.83M -37.28M -2.57B -37.89M -255M -99.89M -1.29B -101M -98.67M -4.27B
Net Debt	-26.8M -23.14M -21.75M -19.78M -37.19M -2.56B -37.8M -255M -99.63M -1.28B -101M -98.42M -4.26B	-39.31M -33.95M -31.9M -29.01M -54.55M -3.76B -55.45M -374M -146M -1.88B -148M -144M -6.25B

Tilray, Inc. Share Price Toronto S.E.

Stocks

APHA

CA03765K1049

Pharmaceuticals

Valuation: Tilray, Inc.

Latest news : Tilray, Inc.

Last Transcript: Tilray, Inc.

Analysts' recommendations: Tilray, Inc.

Press Releases: Tilray, Inc.

News in other languages: Tilray, Inc.

Quotes and Performance

Managers and Directors: Tilray, Inc.

Other Pharmaceuticals

Financials

Company Profile